These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2150954)

  • 1. Fluorometric estimation of the photosensitizing drug, Photofrin II (polyhaematoporphyrin).
    Holroyd JA; Vernon DI; Brown SB
    Biochem Soc Trans; 1990 Dec; 18(6):1264-5. PubMed ID: 2150954
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative in vivo measurement of the fluorescent components of Photofrin II.
    Schneckenburger H; Feyh J; Götz A; Frenz M; Brendel W
    Photochem Photobiol; 1987 Nov; 46(5):765-8. PubMed ID: 2964663
    [No Abstract]   [Full Text] [Related]  

  • 3. Photodynamic therapy of human bladder cancer cells in vitro correlated with cellular fluorescence levels of Photofrin-II.
    Williams RD; Runge TC
    Photochem Photobiol; 1987 Nov; 46(5):733-7. PubMed ID: 2964661
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of fluorescent polyporphyrin Photofrin II in normal rat tissue and rat bladder tumor.
    Baumgartner R; Fuchs N; Jocham D; Stepp H; Unsöld E
    Photochem Photobiol; 1992 Apr; 55(4):569-74. PubMed ID: 1535712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of medium polarity on the photosensitizing properties of hematoporphyrin and hematoporphyrin derivative (Photofrin II).
    Shopova M; Gantchev T
    J Photochem Photobiol B; 1988 Nov; 2(3):365-71. PubMed ID: 2853216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro photodynamic treatment of normal and human papilloma virus-transfected keratinocytes with photofrin II and red light.
    Bernstein EF; Glass JM; DeGraff WG; Schlegel R; Black C; Fisher JM; Cook SN; Glatstein E; Russo A; Mitchell JB
    Arch Dermatol; 1991 May; 127(5):683-7. PubMed ID: 1850973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematoporphyrin ethers--III. Cellular uptake and photosensitizing properties.
    Moan J; Rimington C; Western A
    Int J Biochem; 1988; 20(12):1401-4. PubMed ID: 2977342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photofrin II localization in rat cecum.
    Bjorkman DJ; Brigham EJ; Peterson BJ; Straight RC
    Lasers Surg Med; 1989; 9(3):286-9. PubMed ID: 2525216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glucose administration on the uptake of photofrin II in a human tumor xenograft.
    Peng Q; Moan J; Cheng LS
    Cancer Lett; 1991 Jun; 58(1-2):29-35. PubMed ID: 1828712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the preparation and properties of dihematoporphyrin ether, the tumor-localizing component of HPD.
    Kessel D; Cheng ML
    Photochem Photobiol; 1985 Mar; 41(3):277-82. PubMed ID: 3160051
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of photofrin II and light energy on retinoblastoma-like cells in vitro. Dose-response relationships, effect of light dose rate and recovery ratio.
    Winther J
    J Cancer Res Clin Oncol; 1989; 115(1):73-8. PubMed ID: 2522095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the structure of porphyrins contained in Photofrin II.
    Dougherty TJ
    Photochem Photobiol; 1987 Nov; 46(5):569-73. PubMed ID: 2964650
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
    Gibson SL; van der Meid KR; Murant RS; Hilf R
    Br J Cancer; 1990 Apr; 61(4):553-7. PubMed ID: 2139578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy in the treatment of pancreatic carcinoma: dihematoporphyrin ether uptake and photobleaching kinetics.
    Mang TS; Wieman TJ
    Photochem Photobiol; 1987 Nov; 46(5):853-8. PubMed ID: 2964666
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution of di-sulfonated aluminum phthalocyanine and Photofrin II in living cells: a comparative fluorometric study.
    Bottiroli G; Croce AC; Ramponi R; Vaghi P
    Photochem Photobiol; 1992 Apr; 55(4):575-88. PubMed ID: 1535713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses and photosensitizing activity of porphyrins joined with ester linkages.
    Pandey RK; Dougherty TJ
    Cancer Res; 1989 Apr; 49(8):2042-7. PubMed ID: 2522815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of light exposure on the uptake of photofrin II in tumors and normal tissues.
    Ma LW; Moan J; Peng Q
    Int J Cancer; 1992 Aug; 52(1):120-3. PubMed ID: 1386841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of multiple photosensitizers and wavelengths during photodynamic therapy: a new approach to enhance tumor eradication.
    Nelson JS; Liaw LH; Lahlum RA; Cooper PL; Berns MW
    J Natl Cancer Inst; 1990 May; 82(10):868-73. PubMed ID: 2139704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of liposomes' membrane composition on the binding of the photosensitizers Hpd and photofrin II.
    Ehrenberg B; Gross E
    Photochem Photobiol; 1988 Oct; 48(4):461-6. PubMed ID: 2976507
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution and elimination of Photofrin II in mice.
    Bellnier DA; Ho YK; Pandey RK; Missert JR; Dougherty TJ
    Photochem Photobiol; 1989 Aug; 50(2):221-8. PubMed ID: 2528753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.